Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621343 | SCV000737377 | likely benign | Cardiovascular phenotype | 2016-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000939523 | SCV001085369 | likely benign | Hypertrophic cardiomyopathy | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001190253 | SCV001357704 | likely benign | Cardiomyopathy | 2020-03-09 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001190253 | SCV002042873 | likely benign | Cardiomyopathy | 2022-12-06 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000939523 | SCV004815467 | likely benign | Hypertrophic cardiomyopathy | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV005404755 | SCV006067043 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing |